Use of tissue inhibitor of metalloproteinase 2 and insulin-like growth factor binding protein 7 [TIMP2]•[IGFBP7] as an AKI risk screening tool to manage patients in the real-world setting
- Resource Type
- Article
- Source
- In
Journal of Critical Care June 2020 57:97-101 - Subject
- Language
- ISSN
- 0883-9441